Review of the evidence: Prevalence of medical conditions in the United States population with serious mental illness

General Hospital Psychiatry

Volumn 37, Issue 3, 2015, Pages 199-222

  Janssen, Ellen M ^a   McGinty, Emma E ^a   Azrin, Susan T ^b   Juliano Bult, Denise ^b   Daumit, Gail L ^c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bipolar disorder; Medical co morbidity; Prevalence; Schizophrenia

Indexed keywords

ARTICLE; BIPOLAR DISORDER; CEREBROVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; EPIDEMIOLOGICAL DATA; EVIDENCE BASED PRACTICE; HEALTH SURVEY; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERLIPIDEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY DISEASE; MALIGNANT NEOPLASTIC DISEASE; MASS SCREENING; MENTAL DISEASE; MORTALITY; OBESITY; OUTCOME ASSESSMENT; PEER REVIEW; POPULATION RESEARCH; PREVALENCE; RISK FACTOR; SCHIZOPHRENIA; UNITED STATES; COMORBIDITY; HEALTH STATUS; MENTAL DISORDERS;

COMORBIDITY; HEALTH STATUS; HUMANS; MENTAL DISORDERS; PREVALENCE; UNITED STATES;

EID: 84930180762     PISSN: 01638343     EISSN: 18737714     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2015.03.004     Document Type: Article

References (118)

1. Druss B.G. Understanding excess mortality in persons with mental illness: 17-year follow up of a nationally representative US survey. Med Care 2011, 49(6):599-604.
2. Newcomer J.W., Hennekens C.H. Severe mental illness and risk of cardiovascular disease. JAMA 2007, 298(15):1794-1796.
3. Daumit G.L., Goldberg R.W., Anthony C., Dickerson F., Brown C.H., Kreyenbuhl J., et al. Physical activity patterns in adults with severe mental illness. J Nerv Ment Dis 2005, 193(10):641-646.
4. McCreadie R.G. Diet, smoking and cardiovascular risk in people with schizophrenia: descriptive study. Br J Psychiatry 2003, 183(6):534-539.
5. Lasser K., Boyd J., Woolhandler S., Himmelstein D.U., McCormick D., Bor D.H. Smoking and mental illness: a population-based prevalence study. JAMA 2000, 284(20):2606-2610.
6. Newcomer J.W. Antipsychotic medications: metabolic and cardiovascular risk. J Clin Psychiatry 2007, 68(Suppl. 4):8-13.
7. McGinty E.E., Zhang Y., Guallar E., Ford D.E., Steinwachs D., Dixon L.B., et al. Cancer incidence in a sample of Maryland residents with serious mental illness. Psychiatr Serv 2012, 63(7):714-717.
8. Jones D.R., Macias C., Barreira P.J., Fisher W.H., Hargreaves W.A., Harding C.M. Prevalence, severity, and co-occurrence of chronic physical health problems of persons with serious mental illness. Psychiatr Serv 2004, 55(11):1250-1257.
9. Rosenberg S.D., Goodman L.A., Osher F.C., Swartz M.S., Essock S.M., Butterfield M.I., et al. Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness. Am J Public Health 2001, 91(1):31-36.
10. Meade C.S., Sikkema K.J. HIV risk behavior among adults with severe mental illness: a systematic review. Clin Psychol Rev 2005, 25(4):433-457.
11. Mueser K.T., McGurk S.R. Schizophrenia. Lancet 2004, 363(9426):2063-2072.
12. Perkins R., Rinaldi M. Unemployment rates among patients with long-term mental health problems: a decade of rising unemployment. Psychiatr Bull 2002, 26(8):295-298.
13. Olfson M., Mechanic D., Hansell S., Boyer C.A., Walkup J. Prediction of homelessness within three months of discharge among inpatients with schizophrenia. Psychiatr Serv 1999, 50(5):667-673.
14. Drake R.E., Skinner J.S., Bond G.R., Goldman H.H. Social security and mental illness: reducing disability with supported employment. Health Aff 2009, 28(3):761-770.
15. Mental health, United States, 2008. HHS Publication No SMA 10-4590 2010, Substance Abuse and Mental Health Administration (SAMHSA), SAMHSA, Rockville, MD.
16. Lantz P.M., House J.S., Lepkowski J.M., Williams D.R., Mero R.P., Chen J. Socioeconomic factors, health behaviors, and mortality: results from a nationally representative prospective study of US adults. JAMA 1998, 279(21):1703-1708.
17. Fiscella K., Franks P., Gold M.R., Clancy C.M. Inequality in quality: addressing socioeconomic, racial, and ethnic disparities in health care. JAMA 2000, 283(19):2579-2584.
18. Marmot M., Wilkinson R. Social determinants of health 2005, Oxford University Press, Oxford, UK.
19. Black J.L., Macinko J. Neighborhoods and obesity. Nutr Rev 2008, 66(1):2-20.
20. Mitchell A.J., Malone D., Doebbeling C.C. Quality of medical care for people with and without comorbid mental illness and substance misuse: systematic review of comparative studies. Br J Psychiatry 2009, 194(6):491-499.
21. Druss B.G., Zhao L., Silke A., Bona J.R., Fricks L., Jenkins-Tucker S., et al. The Health and Recovery Peer (HARP) Program: a peer-led intervention to improve medical self-management for persons with serious mental illness. Schizophr Res 2010, 118(1):264-270.
22. Kreyenbuhl J., Dixon L.B., McCarthy J.F., Soliman S., Ignacio R.V., Valenstein M. Does adherence to medications for type 2 diabetes differ between individuals with vs without schizophrenia?. Schizophr Bull 2010, 36(2):428-435.
23. Ösby U., Brandt L., Correia N., Ekbom A., Sparén P. Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry 2001, 58(9):844-850.
24. Enger C., Weatherby L., Reynolds R.F., Glasser D.B., Walker A.M. Serious cardiovascular events and mortality among patients with schizophrenia. J Nerv Ment Dis 2004, 192(1):19-27.
25. Laursen T.M., Munk-Olsen T., Agerbo E., Gasse C., Mortensen P.B. Somatic hospital contacts, invasive cardiac procedures, and mortality from heart disease in patients with severe mental disorder. Arch Gen Psychiatry 2009, 66(7):713-720.
26. Chang C.-K., Hayes R.D., Perera G., Broadbent M.T., Fernandes A.C., Lee W.E., et al. Life expectancy at birth for people with serious mental illness and other major disorders from a secondary mental health care case register in London. PLoS One 2011, 6(5):e19590.
27. National health interview survey Centers for Disease Control and Prevention. http://www.cdc.gov/nchs/nhis.htm.
28. Behavioral risk factor surveillance system Centers for Disease Control and Prevention (CDC). http://www.cdc.gov/brfss/.
29. National health and nutrition examination survey Centers for Disease Control and Prevention. http://www.cdc.gov/nchs/nhanes.htm.
30. Fletcher R.H., Fletcher S.W., Fletcher G.S. Clinical epidemiology: the essentials 2012, Lippincott Williams & Wilkins, Philadelphia, PA.
31. Kessler R.C., Berglund P.A., Bruce M.L., Koch J.R., Laska E.M., Leaf P.J., et al. The prevalence and correlates of untreated serious mental illness. Health Serv Res 2001, 36(6 Pt 1):987-1007.
32. Veldhuizen S., Cairney J., Kurdyak P., Streiner D.L. The sensitivity of the K6 as a screen for any disorder in community mental health surveys: a cautionary note. Can J Psychiatry/La Rev Can Psychiatr 2007, 52(4):256-259.
33. Bradford D.W., Cunningham N.T., Slubicki M.N., McDuffie J.R., Kilbourne A.M., Nagi A., et al. An evidence synthesis of care models to improve general medical outcomes for individuals with serious mental illness: a systematic review. J Clin Psychiatry 2013, 74(8):e754-e764.
34. Miller B.J., Paschall C.B., Svendsen D.P. Mortality and medical comorbidity among patients with serious mental illness. Psychiatr Serv 2006, 57(10):1482-1487.
35. Parks J., Svendsen D., Singer P., Foti M.E. Morbidity and mortality in people with serious mental illness 2006, National Association of State Mental Health Program Directors (NASMHPD) Medical Directors Council, Alexandria.
36. Schizophrenia Health NIOM. http://www.nimh.nih.gov/health/topics/schizophrenia/index.shtml.
37. Bipolar disorder National Institute of Mental Health. https://www.nimh.nih.gov/health/statistics/prevalence/_148124.pdf.
38. National Health and Nutrition Examination Survey 2011-2012 overview Centers for Disease Control and Prevention. http://www.cdc.gov/nchs/nhanes/nhanes2011-2012/overview_g.htm.
39. Kessler R.C., Berglund P., Chiu W.T., Demler O., Heeringa S., Hiripi E., et al. The US National Comorbidity Survey Replication (NCS-R): design and field procedures. Int J Methods Psychiatr Res 2004, 13(2):69-92.
40. Riva J.J., Malik K.M., Burnie S.J., Endicott A.R., Busse J.W. What is your research question? An introduction to the PICOT format for clinicians. J Can Chiropr Assoc 2012, 56(3):167-171.
41. Fiscella K., Holt K., Meldrum S., Franks P. Disparities in preventive procedures: comparisons of self-report and Medicare claims data. BMC Health Serv Res 2006, 6(1):122-130.
42. Tang P.C., Ralston M., Arrigotti M.F., Qureshi L., Graham J. Comparison of methodologies for calculating quality measures based on administrative data versus clinical data from an electronic health record system: implications for performance measures. J Am Med Inform Assoc 2007, 14(1):10-15.
43. Bell R.C., Farmer S., Ries R., Srebnik D. Metabolic risk factors among medicaid outpatients with schizophrenia receiving second-generation antipsychotics. Psychiatr Serv 2009, 60(12):1686-1689.
44. Chwastiak L.A., Rosenheck R.A., McEvoy M., Stroup T.S., Swartz M.S., Davis S.M., et al. The impact of obesity on health care costs among persons with schizophrenia. Gen Hosp Psychiatry 2009, 31(1):1-7.
45. Conley R.R., Shim J.C., Kelly D.L., Feldman S., Yu Y., McMahon R.P. Cardiovascular disease in relation to weight in deceased persons with schizophrenia. Compr Psychiatry 2005, 46(6):460-467.
46. Correll C.U., Druss B.G., Lombardo I., O'Gorman C., Harnett J.P., Sanders K.N., et al. Findings of a U.S. National Cardiometabolic Screening Program among 10,084 psychiatric outpatients. Psychiatr Serv 2010, 61(9):892-898.
47. Correll C.U., Frederickson A.M., Kane J.M., Manu P. Equally increased risk for metabolic syndrome in patients with bipolar disorder and schizophrenia treated with second-generation antipsychotics. Bipolar Disord 2008, 10(7):788-797.
48. McElroy S.L., Frye M.A., Suppes T., Dhavale D., Keck P.E., Leverich G.S., et al. Correlates of overweight and obesity in 644 patients with bipolar disorder. J Clin Psychiatry 2002, 63(3):207-213.
49. Rothbard A.B., Blank M.B., Staab J.P., TenHave T., Young D.S., Berry S.D., et al. Previously undetected metabolic syndromes and infectious diseases among psychiatric inpatients. Psychiatr Serv 2009, 60(4):534-537.
50. Susce M.T., Villanueva N., Diaz F.J., de Leon J. Obesity and associated complications in patients with severe mental illnesses: a cross-sectional survey. J Clin Psychiatry 2005, 66(2):167-173.
51. Wang P.W., Sachs G.S., Zarate C.A., Marangell L.B., Calabrese J.R., Goldberg J.F., et al. Overweight and obesity in bipolar disorders. J Psychiatr Res 2006, 40(8):762-764.
52. Fiedorowicz J.G., Palagummi N.M., Forman-Hoffman V.L., Miller D.D., Haynes W.G. Elevated prevalence of obesity, metabolic syndrome, and cardiovascular risk factors in bipolar disorder. Ann Clin Psychiatry 2008, 20(3):131-137.
53. Goldstein B.I., Liu S.M., Zivkovic N., Schaffer A., Chien L.C., Blanco C. The burden of obesity among adults with bipolar disorder in the United States. Bipolar Disord 2011, 13(4):387-395.
54. Chwastiak L.A., Rosenheck R.A., Kazis L.E. Association of psychiatric illness and obesity, physical inactivity, and smoking among a national sample of veterans. Psychosomatics 2011, 52(3):230-236.
55. Goldstein B.I., Fagiolini A., Houck P., Kupfer D.J. Cardiovascular disease and hypertension among adults with bipolar I disorder in the United States. Bipolar Disord 2009, 11(6):657-662.
56. Morden N.E., Lai Z., Goodrich D.E., et al. Eight-year trends of cardiometabolic morbidity and mortality in patients with schizophrenia. Gen Hosp Psychiatry 2012, 34(4):368-379.
57. Health, United States, 2013 Centers for Disease Control and Prevention. http://www.cdc.gov/nchs/data/hus/hus13.pdf.
58. Prevalence and trends data Centers for Disease Control and Prevention. http://apps.nccd.cdc.gov/brfss/.
59. Kilbourne A.M., Brar J.S., Drayer R.A., Xu X., Post E.P. Cardiovascular disease and metabolic risk factors in male patients with schizophrenia, schizoaffective disorder, and bipolar disorder. Psychosomatics 2007, 48(5):412-417.
60. Carney C.P., Jones L.E. Medical comorbidity in women and men with bipolar disorders: a population-based controlled study. Psychosom Med 2006, 68(5):684-691.
61. Carney C.P., Jones L., Woolson R.F. Medical comorbidity in women and men with schizophrenia: a population-based controlled study. J Gen Intern Med 2006, 21(11):1133-1137.
62. Kilbourne A.M., Cornelius J.R., Han X., Pincus H.A., Shad M., Salloum I., et al. Burden of general medical conditions among individuals with bipolar disorder. Bipolar Disord 2004, 6(5):368-373.
63. Kilbourne A.M., Morden N.E., Austin K., Ilgen M., McCarthy J.F., Dalack G., et al. Excess heart-disease-related mortality in a national study of patients with mental disorders: identifying modifiable risk factors. Gen Hosp Psychiatry 2009, 31(6):555-563.
64. Duncan E., Dunlop B.W., Boshoven W., Woolson S.L., Hamer R.M., Phillips L.S. Relative risk of glucose elevation during antipsychotic exposure in a Veterans Administration population. Int Clin Psychopharmacol 2007, 22(1):1-11.
65. Levine J., Chengappa K.N., Patel A., Vagnucci A., John V., Brar J.S., et al. Obesity and medical illnesses in psychiatric patients admitted to a long-term psychiatric facility. J Psychiatr Pract 2001, 7(6):432-439.
66. Duncan E.J., Woolson S.L., Hamer R.M., Dunlop B.W. Risk of lipid abnormality with haloperidol, olanzapine, quetiapine, and risperidone in a Veterans Affairs population. Int Clin Psychopharmacol 2009, 24(4):204-213.
67. Barner J.C., Worchel J., Yang M. Frequency of new-onset diabetes mellitus and use of antipsychotic drugs among Central Texas veterans. Pharmacotherapy 2004, 24(11):1529-1538.
68. de Leon J., Susce M.T., Johnson M., et al. A clinical study of the association of antipsychotics with hyperlipidemia. Schizophr Res 2007, 92(1-3):95-102.
69. Chwastiak L.A., Rosenheck R.A., McEvoy J.P., Keefe R.S., Swartz M.S., Lieberman J.A. Interrelationships of psychiatric symptom severity, medical comorbidity, and functioning in schizophrenia. Psychiatr Serv 2006, 57(8):1102-1109.
70. Argo T., Carnahan R., Barnett M., Holman T.L., Perry P.J. Diabetes prevalence estimates in schizophrenia and risk factor assessment. Ann Clin Psychiatry 2011, 23(2):117-124.
71. Total and high-density lipoprotein cholesterol in adults: National Health and Nutrition Examination Survey, 2009-2010 Centers for Disease Control and Prevention. http://www.cdc.gov/nchs/data/databriefs/db92.htm.
72. Dickey B., Normand S.L.T., Weiss R.D., Drake R.E., Azeni H. Medical morbidity, mental illness, and substance use disorders. Psychiatr Serv 2002, 53(7):861-867.
73. Weber N.S., Cowan D.N., Millikan A.M., Niebuhr D.W. Psychiatric and general medical conditions comorbid with schizophrenia in the National Hospital Discharge Survey. Psychiatr Serv 2009, 60(8):1059-1067.
74. Chafetz L., White M.C., Collins-Bride G., Nickens J. The poor general health of the severely mentally ill: impact of schizophrenic diagnosis. Community Ment Health J 2005, 41(2):169-184.
75. Correll C.U., Frederickson A.M., Kane J.M., Manu P. Does antipsychotic polypharmacy increase the risk for metabolic syndrome?. Schizophr Res 2007, 89(1-3):91-100.
76. Sokal J., Messias E., Dickerson F.B., Kreyenbuhl J., Brown C.H., Goldberg R.W., et al. Comorbidity of medical illnesses among adults with serious mental illness who are receiving community psychiatric services. J Nerv Ment Dis 2004, 192(6):421-427.
77. Goff D.C., Sullivan L.M., McEvoy J.P., Meyer J.M., Nasrallah H.A., Daumit G.L., et al. A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls. Schizophr Res 2005, 80(1):45-53.
78. Daumit G.L., Goff D.C., Meyer J.M., Davis V.G., Nasrallah H.A., McEvoy J.P., et al. Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study. Schizophr Res 2008, 105(1-3):175-187.
79. McEvoy J.P., Meyer J.M., Goff D.C., Nasrallah H.A., Davis S.M., Sullivan L., et al. Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Schizophrenia Trial and comparison with national estimates from NHANES III. Schizophr Res 2005, 80(1):19-32.
80. Perron B.E., Howard M.O., Nienhuis J.K., Bauer M.S., Woodward A.T., Kilbourne A.M. Prevalence and burden of general medical conditions among adults with bipolar I disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 2009, 70(10):1407-1415.
81. Dixon L., Medoff D.R., Wohlheiter K., DiClemente C., Goldberg R., Kreyenbuhl J., et al. Correlates of severity of smoking among persons with severe mental illness. Am J Addict 2007, 16(2):101-110.
82. Atlantis E., Shi Z., Penninx B.J.W.H., Wittert G.A., Taylor A., Almeida O.P. Chronic medical conditions mediate the association between depression and cardiovascular disease mortality. Soc Psychiatry Psychiatr Epidemiol 2012, 47(4):615-625.
83. Hypertension among adults in the United States, 2009-2010 Centers for Disease Control and Prevention. http://www.cdc.gov/nchs/data/databriefs/db107.htm.
84. Lambert M.T., Copeland L.A., Sampson N., Duffy S.A. New-onset type-2 diabetes associated with atypical antipsychotic medications. Prog Neuro-Psychopharmacol Biol Psychiatry 2006, 30(5):919-923.
85. National Diabetes Statistics Report, 2014 Centers for Disease Control and Prevention. http://www.cdc.gov/diabetes/pdfs/data/2014-report-estimates-of-diabetes-and-its-burden-in-the-united-states.pdf.
86. Beyer J., Kuchibhatla M., Gersing K., Krishnan K.R.R. Medical comorbidity in a bipolar outpatient clinical population. Neuropsychopharmacology 2005, 30(2):401-404.
87. McDermott S., Moran R., Platt T., Isaac T., Wood H., Dasari S. Heart disease, schizophrenia, and affective psychoses: epidemiology of risk in primary care. Community Ment Health J 2005, 41(6):747-755.
88. Correll C.U., Kane J.M., Manu P. Identification of high-risk coronary heart disease patients receiving atypical antipsychotics: single low-density lipoprotein cholesterol threshold or complex national standard?. J Clin Psychiatry 2008, 69(4):578-583.
89. Go A.S., Mozaffarian D., Roger V.L., Benjamin E.J., Berry J.D., Bravata D.M., et al. Heart disease and stroke statistics - 2013 update. Circulation 2012, 127:e6-e245.
90. Prevalence and trends data - cardiovascular disease 2010 Centers for Disease Control and Prevention. http://apps.nccd.cdc.gov/brfss/list.asp?cat=CV&yr=2010&qkey=5021&state=All.
91. Chronic obstructive pulmonary disease among adults - United States, 2011 Centers for Disease Control and Prevention. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6146a2.htm?s_cid=mm6146a2_w.
92. Chronic kidney disease in the NHANES population United States Renal Data System. http://www.usrds.org/2008/pdf/V1_01_2008.pdf.
93. Underwood J., Townsend J.S., Stewart S.L., Buchannan N., Ekwueme D.U., Hawkins N.A., et al. Surveillance of demographic characteristics and health behaviors among adult cancer survivors - behavioral risk fact. Morb Mortal Wkly Rep 2012, 20(61):1-23.
94. Butterfield M.I., Bosworth H.B., Stechuchak K.M., Frothingham R., Bastian L.A., Meador K.G., et al. Racial differences in hepatitis B and hepatitis C and associated risk behaviors in veterans with severe mental illness. J Natl Med Assoc 2004, 96(1):43-52.
95. Meyer J.M. Prevalence of hepatitis A, hepatitis B, and HIV among hepatitis C-seropositive state hospital patients: results from Oregon State Hospital. J Clin Psychiatry 2003, 64(5):540-545.
96. Rosenberg S.D., Drake R.E., Brunette M.F., Wolford G.L., Marsh B.J. Hepatitis C virus and HIV co-infection in people with severe mental illness and substance use disorders. AIDS 2005, 19(Suppl. 3):S26-S33.
97. Butterfield M.I., Bosworth H.B., Meador K.G., Stechuchak K.M., Essock S.M., Osher F.C., et al. Gender differences in hepatitis C infection and risks among persons with severe mental illness. Psychiatr Serv 2003, 54(6):848-853.
98. Osher F.C., Goldberg R.W., McNary S.W., Swartz M.S., Essock S.M., Butterfield M.I., et al. Substance abuse and the transmission of hepatitis C among persons with severe mental illness. Psychiatr Serv 2003, 54(6):842-847.
99. Matthews A.M., Huckans M.S., Blackwell A.D., Hauser P. Hepatitis C testing and infection rates in bipolar patients with and without comorbid substance use disorders. Bipolar Disord 2008, 10(2):266-270.
100. Huckans M.S., Blackwell A.D., Harms T.A., Hauser P. Management of hepatitis C disease among VA patients with schizophrenia and substance use disorders. Psychiatr Serv 2006, 57(3):403-406.
101. Himelhoch S., McCarthy J.F., Ganoczy D., Medoff D., Dixon L.B., Blow F.C.B. Understanding associations between serious mental illness and HIV among patients in the VA health system. Psychiatr Serv 2007, 58(9):1165-1172.
102. Fuller B.E., Rodriguez V.L., Linke A., Sikirica M., Dirani R., Hauser P. Prevalence of liver disease in veterans with bipolar disorder or schizophrenia. Gen Hosp Psychiatry 2011, 33(3):232-237.
103. Kim R. Epidemiology of hepatitis B in the United States. Hepatology 2009, 49(5):S28-S34.
104. Denniston M.M., Jiles R.B., Drobeniuc J., et al. Chronic hepatitis C infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010. Ann Intern Med 2014, 160(5):13-1133.
105. Carey M.P., Carey K.B., Maisto S.A., Schroder K.E., Vanable P.A., Gordon C.M. HIV risk behavior among psychiatric outpatients: association with psychiatric disorder, substance use disorder, and gender. J Nerv Ment Dis 2004, 192(4):289-296.
106. Walkup J.T., Akincigil A., Amin S., Hoover D., Siegel M., Crystal S. Prevalence of diagnosed HIV disease among medicaid beneficiaries with schizophrenia in U.S. metropolitan areas. J Nerv Ment Dis 2010, 198(9):682-686.
107. Walkup J., Akincigil A., Hoover D.R., Siegel M.J., Amin S., Crystal S. Use of Medicaid data to explore community characteristics associated with HIV prevalence among beneficiaries with schizophrenia. Public Health Rep 2011, 126(Suppl. 3):89-101.
108. Blank M.B., Mandell D.S., Aiken L., Hadley T.R. Co-occurrence of HIV and serious mental illness among Medicaid recipients. Psychiatr Serv 2002, 53(7):868-873.
109. McQuillan G.M., Kruszon-Moran D. HIV infection in the United States household population aged 18-49 years: results 1999-2006. NCHS Data Brief 2008, [http://www.cdc.gov/nchs/data/databriefs/db04.pdf].
110. Hattori A., Sturm R. The obesity epidemic and changes in self-report biases in BMI. Obesity (Silver Spring) 2013, 21(4):856-860.
111. Klabunde C.N., Warren J.L., Legler J.M. Assessing comorbidity using claims data: an overview. Med Care 2002, 40(8):IV-26-IV-35.
112. Khaykin E., Eaton W.W., Ford D.E., Anthony C.B., Daumit G.L. Health insurance coverage among persons with schizophrenia in the United States. Psychiatr Serv 2010, 61(8):830-834.
113. Rittenhouse D.R., Shortell S.M., Fisher E.S. Primary care and accountable care - two essential elements of delivery-system reform. N Engl J Med 2009, 361(24):2301-2303.
114. Kindig D.A., Asada Y., Booske B. A population health framework for setting national and state health goals. JAMA 2008, 299(17):2081-2083.
115. Sandberg S.F., Erikson C., Owen R., Vickery K.D., Shimotsu S.T., Linzer M., et al. Hennepin Health: a safety-net accountable care organization for the expanded Medicaid population. Health Aff 2014, 33(11):1975-1984.
116. eMedicaid Instructions Maryland Department of Health and Mental Hygiene. http://dhmh.maryland.gov/bhd/Documents/HH_eMedicaidInstructions_10_2_13.pdf.
117. Spillman B.C., Ormond B.A., Richardson E.R. Medicaid health homes in Missouri http://aspe.hhs.gov/daltcp/reports/2012/HHOption-MO.pdf.
118. McGinty E.E., Daumit G.L. Epidemiology of obesity. Psychiatr Ann 2011, 41(10):484-488.